These three healthcare pioneers have slid down to nice prices that investors should take advantage of this month.
News & Analysis: Guardant Health
Is Wall Street's initial excitement giving way to more realistic expectations?
Depending on one customer for too much revenue is generally a red flag, but the intentional growth strategy of Personalis is worth paying closer attention to.
The Rule of 40 is a quick and dirty way to value stocks before you add them to your portfolio.
Success is in these three great healthcare stocks' DNA.
Find out why these new healthcare stocks keep climbing, while most of their peers have underwhelmed.
Which stock wins in a matchup between a gene sequencing pioneer and a fast-rising liquid biopsy leader?
These forward-looking companies are riding trends in consumer spending, cloud computing, and cancer screening.
Summer is winding down. But these three stocks should be hot for a long time to come.
Investors worried about a couple of insider trades put pressure on the stock price.